Noveome Biotherapeutics, Inc. Receives FDA Notification to Proceed with its Phase 1-2 Clinical Trial in Treatment of NEC
PITTSBURGH, PA, UNITED STATES, December 11, 2023 /EINPresswire.com/ -- Noveome Biotherapeutics, Inc. Receives FDA Notification to Proceed with its Part ...
